-
Amentoflavone Impedes NF-κB Activation and Mediates Apoptosis Induction in Lung Cancer Cells: An in vitro and in silico exploration
01 Jul 2025 12:03 GMT
… clinical management of lung cancer by investigating various … to therapeutic interventions in lung cancer.20,21 Consequently, … (b) amentoflavone, (c) doxorubicin, (d) JSH-23, and … treatment of cancers, including lung cancer. Currently, available therapeutic …
-
Theranostic Role of Advanced Nanotechnological Tools in Early Brain Metastases in Lung Cancer: An Updated Review
05 Jun 2025 21:28 GMT
… cells from the initial lung tumor, their migration into … Brain Metastasis in Lung Cancer. Primary lung cancer cells move from … In contrast to original lung tumors, which might manifest … formulations is liposome-encapsulated doxorubicin (Doxil), which is …
-
Race Oncology doses first patient in trial of RC220 + doxorubicin...
19 Jun 2025 03:01 GMT
… cardiotoxicity commonly associated with doxorubicin, a widely used … of cardiotoxicity related to doxorubicin therapy.”
This trial … as breast, ovarian and lung cancer, among others.
Global … its promising combination with doxorubicin could potentially provide …
-
In vivo Targeted Delivery of Extracellular Vesicle‒Gold Nanorod Hybrids to Metastatic Melanoma Lung Tumors
30 May 2025 18:07 GMT
… of metastatic melanoma lung tumors in vivo with … al. Targeted delivery of doxorubicin by nano-loaded mesenchymal … study protocol among advanced lung cancer patients. Front Public Health … accumulation in small metastatic lung tumors. J Nanobiotechnology. 2020 …
-
Merck Announces MK-1084, an Investigational KRAS G12C Inhibitor, Shows Antitumor Activity in Phase 1 Trial of Patients With Advanced Colorectal Cancer and Non-Small Cell Lung Cancer Whose Tumors Harbor KRAS G12C Mutations
30 May 2025 12:21 GMT
… ) and non-small cell lung cancer (NSCLC). In patients with … test.
Non-Small Cell Lung Cancer
KEYTRUDA, in combination with … nonsquamous non-small cell lung cancer (NSCLC), with no … and paclitaxel followed by doxorubicin or epirubicin and cyclophosphamide) …
-
Advancements in Nanocarrier Delivery Systems for Photodynamic Therapy in Lung Cancer
28 May 2025 23:23 GMT
… has surpassed lung cancer in incidence, lung cancer remains the … -stage lung cancer.65 In 2002, Japanese lung cancer treatment … stage central lung cancer.68 However, most lung cancer cases … 2 cell membranes, encapsulating doxorubicin (DOX), showed prolonged …
-
Building a BioCypher-Powered AI Agent for Biomedical Knowledge Graph Generation and Querying
03 Jul 2025 11:57 GMT
… ;: ["breast_cancer", "lung_cancer", "diabetes", … ", "metformin", "doxorubicin", "paclitaxel", …
-
Strategic Optimization of Nanoparticle Characteristics to Enhance Tumor Targeting and Doxorubicin Delivery
20 May 2025 21:47 GMT
… metastases. Chemotherapeutics such as doxorubicin (Dox), epirubicin, paclitaxel … breast cancer,3 lung cancer,4 sarcomas,5 … human lung cancer cells, and H226 murine lung cancer cells … Characterization of ELP–Doxorubicin Conjugates and Characterization
…
-
Golidocitinib Plus PD-1 Antibodies Being Explored in Lung Cancer Subset
20 Mar 2025 21:43 GMT
… patients with non-small cell lung cancer (NSCLC), treatment with the Janus … month at the 2025 European Lung Cancer Congress (ELCC) in Paris.
As … works with or without cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) in …
-
LncRNA CCAT1 decreases the sensitivity to doxorubicin in lung cancer cells by regulating miR-181a/CPEB2 axis.
17 Mar 2025 09:18 GMT
… amount of attention in treating lung cancer. However, a full understanding … CCAT1 on the lung cancer cell proliferation, apoptosis, and doxorubicin (DOX) sensitivity, … CCAT1 decreased the sensitivity to doxorubicin in lung cancer cells by regulating the …
About
© 1995-2025